Skip to main content
Top
Published in: Virology Journal 1/2007

Open Access 01-12-2007 | Methodology

Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes

Authors: Myrna C Bonaldo, Samanta M Mello, Gisela F Trindade, Aymara A Rangel, Adriana S Duarte, Prisciliana J Oliveira, Marcos S Freire, Claire F Kubelka, Ricardo Galler

Published in: Virology Journal | Issue 1/2007

Login to get access

Abstract

Background

The yellow fever virus, a member of the genus Flavivirus, is an arthropod-borne pathogen causing severe disease in humans. The attenuated yellow fever 17D virus strain has been used for human vaccination for 70 years and has several characteristics that are desirable for the development of new, live attenuated vaccines. We described here a methodology to construct a viable, and immunogenic recombinant yellow fever 17D virus expressing a green fluorescent protein variant (EGFP). This approach took into account the presence of functional motifs and amino acid sequence conservation flanking the E and NS1 intergenic region to duplicate and fuse them to the exogenous gene and thereby allow the correct processing of the viral polyprotein precursor.

Results

YF 17D EGFP recombinant virus was grew in Vero cells and reached a peak titer of approximately 6.45 ± 0.4 log10 PFU/mL at 96 hours post-infection. Immunoprecipitation and confocal laser scanning microscopy demonstrated the expression of the EGFP, which was retained in the endoplasmic reticulum and not secreted from infected cells. The association with the ER compartment did not interfere with YF assembly, since the recombinant virus was fully competent to replicate and exit the cell. This virus was genetically stable up to the tenth serial passage in Vero cells. The recombinant virus was capable to elicit a neutralizing antibody response to YF and antibodies to EGFP as evidenced by an ELISA test. The applicability of this cloning strategy to clone gene foreign sequences in other flavivirus genomes was demonstrated by the construction of a chimeric recombinant YF 17D/DEN4 virus.

Conclusion

This system is likely to be useful for a broader live attenuated YF 17D virus-based vaccine development for human diseases. Moreover, insertion of foreign genes into the flavivirus genome may also allow in vivo studies on flavivirus cell and tissue tropism as well as cellular processes related to flavivirus infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Monath TP: Yellow fever vaccine. Vaccines. Edited by: Plotkin SAOWA. 2004, Philadelphia, W.B. Saunders, 1095-1176. Fourth edition Monath TP: Yellow fever vaccine. Vaccines. Edited by: Plotkin SAOWA. 2004, Philadelphia, W.B. Saunders, 1095-1176. Fourth edition
2.
go back to reference Co MD, Terajima M, Cruz J, Ennis FA, Rothman AL: Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology. 2002, 293: 151-163. 10.1006/viro.2001.1255.PubMedCrossRef Co MD, Terajima M, Cruz J, Ennis FA, Rothman AL: Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology. 2002, 293: 151-163. 10.1006/viro.2001.1255.PubMedCrossRef
3.
go back to reference Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B: Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med. 2006, 203: 413-424. 10.1084/jem.20051720.PubMedPubMedCentralCrossRef Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B: Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med. 2006, 203: 413-424. 10.1084/jem.20051720.PubMedPubMedCentralCrossRef
4.
go back to reference Tao D, Barba-Spaeth G, Rai U, Nussenzweig V, Rice CM, Nussenzweig RS: Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med. 2005, 201: 201-209. 10.1084/jem.20041526.PubMedPubMedCentralCrossRef Tao D, Barba-Spaeth G, Rai U, Nussenzweig V, Rice CM, Nussenzweig RS: Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med. 2005, 201: 201-209. 10.1084/jem.20041526.PubMedPubMedCentralCrossRef
5.
go back to reference van der Most RG, Harrington LE, Giuggio V, Mahar PL, Ahmed R: Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. Virology. 2002, 296: 117-124. 10.1006/viro.2002.1432.PubMedCrossRef van der Most RG, Harrington LE, Giuggio V, Mahar PL, Ahmed R: Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. Virology. 2002, 296: 117-124. 10.1006/viro.2002.1432.PubMedCrossRef
6.
go back to reference Bonaldo MC, Garratt RC, Caufour PS, Freire MS, Rodrigues MM, Nussenzweig RS, Galler R: Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. J Mol Biol. 2002, 315: 873-885. 10.1006/jmbi.2001.5258.PubMedCrossRef Bonaldo MC, Garratt RC, Caufour PS, Freire MS, Rodrigues MM, Nussenzweig RS, Galler R: Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. J Mol Biol. 2002, 315: 873-885. 10.1006/jmbi.2001.5258.PubMedCrossRef
7.
go back to reference Pugachev KV, Guirakhoo F, Monath TP: New developments in flavivirus vaccines with special attention to yellow fever. Curr Opin Infect Dis. 2005, 18: 387-394. 10.1097/01.qco.0000178823.28585.ad.PubMedCrossRef Pugachev KV, Guirakhoo F, Monath TP: New developments in flavivirus vaccines with special attention to yellow fever. Curr Opin Infect Dis. 2005, 18: 387-394. 10.1097/01.qco.0000178823.28585.ad.PubMedCrossRef
8.
go back to reference Bonaldo MC, Garratt RC, Marchevsky RS, Coutinho ES, Jabor AV, Almeida LF, Yamamura AM, Duarte AS, Oliveira PJ, Lizeu JO, Camacho LA, Freire MS, Galler R: Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface. J Virol. 2005, 79: 8602-8613. 10.1128/JVI.79.13.8602-8613.2005.PubMedPubMedCentralCrossRef Bonaldo MC, Garratt RC, Marchevsky RS, Coutinho ES, Jabor AV, Almeida LF, Yamamura AM, Duarte AS, Oliveira PJ, Lizeu JO, Camacho LA, Freire MS, Galler R: Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface. J Virol. 2005, 79: 8602-8613. 10.1128/JVI.79.13.8602-8613.2005.PubMedPubMedCentralCrossRef
9.
go back to reference Lai CJ, Monath TP: Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv Virus Res. 2003, 61: 469-509.PubMedCrossRef Lai CJ, Monath TP: Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv Virus Res. 2003, 61: 469-509.PubMedCrossRef
10.
go back to reference McAllister A, Arbetman AE, Mandl S, Pena-Rossi C, Andino R: Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. J Virol. 2000, 74: 9197-9205. 10.1128/JVI.74.19.9197-9205.2000.PubMedPubMedCentralCrossRef McAllister A, Arbetman AE, Mandl S, Pena-Rossi C, Andino R: Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. J Virol. 2000, 74: 9197-9205. 10.1128/JVI.74.19.9197-9205.2000.PubMedPubMedCentralCrossRef
11.
go back to reference Barba-Spaeth G, Longman RS, Albert ML, Rice CM: Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med. 2005, 202: 1179-1184. 10.1084/jem.20051352.PubMedPubMedCentralCrossRef Barba-Spaeth G, Longman RS, Albert ML, Rice CM: Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med. 2005, 202: 1179-1184. 10.1084/jem.20051352.PubMedPubMedCentralCrossRef
12.
go back to reference Mutebi JP, Rijnbrand RC, Wang H, Ryman KD, Wang E, Fulop LD, Titball R, Barrett AD: Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region. J Virol. 2004, 78: 9652-9665. 10.1128/JVI.78.18.9652-9665.2004.PubMedPubMedCentralCrossRef Mutebi JP, Rijnbrand RC, Wang H, Ryman KD, Wang E, Fulop LD, Titball R, Barrett AD: Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region. J Virol. 2004, 78: 9652-9665. 10.1128/JVI.78.18.9652-9665.2004.PubMedPubMedCentralCrossRef
13.
go back to reference Andino R, McCallister A: Recombinant bicistronic flaviviruses and methods of use thereof. 2002, US, Andino R, McCallister A: Recombinant bicistronic flaviviruses and methods of use thereof. 2002, US,
14.
go back to reference Pierson TC, Diamond MS, Ahmed AA, Valentine LE, Davis CW, Samuel MA, Hanna SL, Puffer BA, Doms RW: An infectious West Nile virus that expresses a GFP reporter gene. Virology. 2005, 334: 28-40. 10.1016/j.virol.2005.01.021.PubMedCrossRef Pierson TC, Diamond MS, Ahmed AA, Valentine LE, Davis CW, Samuel MA, Hanna SL, Puffer BA, Doms RW: An infectious West Nile virus that expresses a GFP reporter gene. Virology. 2005, 334: 28-40. 10.1016/j.virol.2005.01.021.PubMedCrossRef
15.
go back to reference Harvey TJ, Liu WJ, Wang XJ, Linedale R, Jacobs M, Davidson A, Le TT, Anraku I, Suhrbier A, Shi PY, Khromykh AA: Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J Virol. 2004, 78: 531-538. 10.1128/JVI.78.1.531-538.2004.PubMedPubMedCentralCrossRef Harvey TJ, Liu WJ, Wang XJ, Linedale R, Jacobs M, Davidson A, Le TT, Anraku I, Suhrbier A, Shi PY, Khromykh AA: Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J Virol. 2004, 78: 531-538. 10.1128/JVI.78.1.531-538.2004.PubMedPubMedCentralCrossRef
16.
go back to reference Tannis LL, Gauthier A, Evelegh C, Parsons R, Nyholt D, Khromykh A, Bramson JL: Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity. Vaccine. 2005, 23: 4189-4194. 10.1016/j.vaccine.2005.04.005.PubMedCrossRef Tannis LL, Gauthier A, Evelegh C, Parsons R, Nyholt D, Khromykh A, Bramson JL: Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity. Vaccine. 2005, 23: 4189-4194. 10.1016/j.vaccine.2005.04.005.PubMedCrossRef
17.
go back to reference Westaway EG, Mackenzie JM, Khromykh AA: Kunjin RNA replication and applications of Kunjin replicons. Adv Virus Res. 2003, 59: 99-140.PubMedCrossRef Westaway EG, Mackenzie JM, Khromykh AA: Kunjin RNA replication and applications of Kunjin replicons. Adv Virus Res. 2003, 59: 99-140.PubMedCrossRef
18.
go back to reference Jones CT, Patkar CG, Kuhn RJ: Construction and applications of yellow fever virus replicons. Virology. 2005, 331: 247-259. 10.1016/j.virol.2004.10.034.PubMedCrossRef Jones CT, Patkar CG, Kuhn RJ: Construction and applications of yellow fever virus replicons. Virology. 2005, 331: 247-259. 10.1016/j.virol.2004.10.034.PubMedCrossRef
19.
go back to reference Mason PW, Shustov AV, Frolov I: Production and characterization of vaccines based on flaviviruses defective in replication. Virology. 2006, 351: 432-443. 10.1016/j.virol.2006.04.003.PubMedPubMedCentralCrossRef Mason PW, Shustov AV, Frolov I: Production and characterization of vaccines based on flaviviruses defective in replication. Virology. 2006, 351: 432-443. 10.1016/j.virol.2006.04.003.PubMedPubMedCentralCrossRef
20.
go back to reference Allison SL, Stiasny K, Stadler K, Mandl CW, Heinz FX: Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol. 1999, 73: 5605-5612.PubMedPubMedCentral Allison SL, Stiasny K, Stadler K, Mandl CW, Heinz FX: Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol. 1999, 73: 5605-5612.PubMedPubMedCentral
21.
go back to reference Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC: The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 1995, 375: 291-298. 10.1038/375291a0.PubMedCrossRef Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC: The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 1995, 375: 291-298. 10.1038/375291a0.PubMedCrossRef
22.
go back to reference Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopadhyay S, Baker TS, Strauss JH, Rossmann MG, Kuhn RJ: Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol. 2003, 10: 907-912. 10.1038/nsb990.PubMedPubMedCentralCrossRef Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopadhyay S, Baker TS, Strauss JH, Rossmann MG, Kuhn RJ: Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol. 2003, 10: 907-912. 10.1038/nsb990.PubMedPubMedCentralCrossRef
23.
go back to reference Mukhopadhyay S, Kuhn RJ, Rossmann MG: A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2005, 3: 13-22. 10.1038/nrmicro1067.PubMedCrossRef Mukhopadhyay S, Kuhn RJ, Rossmann MG: A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2005, 3: 13-22. 10.1038/nrmicro1067.PubMedCrossRef
24.
go back to reference Op De Beeck A, Molenkamp R, Caron M, Ben Younes A, Bredenbeek P, Dubuisson J: Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope. J Virol. 2003, 77: 813-820. 10.1128/JVI.77.2.813-820.2003.PubMedPubMedCentralCrossRef Op De Beeck A, Molenkamp R, Caron M, Ben Younes A, Bredenbeek P, Dubuisson J: Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope. J Virol. 2003, 77: 813-820. 10.1128/JVI.77.2.813-820.2003.PubMedPubMedCentralCrossRef
25.
go back to reference Cocquerel L, Wychowski C, Minner F, Penin F, Dubuisson J: Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J Virol. 2000, 74: 3623-3633. 10.1128/JVI.74.8.3623-3633.2000.PubMedPubMedCentralCrossRef Cocquerel L, Wychowski C, Minner F, Penin F, Dubuisson J: Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J Virol. 2000, 74: 3623-3633. 10.1128/JVI.74.8.3623-3633.2000.PubMedPubMedCentralCrossRef
26.
go back to reference Higy M, Junne T, Spiess M: Topogenesis of membrane proteins at the endoplasmic reticulum. Biochemistry. 2004, 43: 12716-12722. 10.1021/bi048368m.PubMedCrossRef Higy M, Junne T, Spiess M: Topogenesis of membrane proteins at the endoplasmic reticulum. Biochemistry. 2004, 43: 12716-12722. 10.1021/bi048368m.PubMedCrossRef
28.
go back to reference Guirakhoo F, Kitchener S, Morrison D, Forrat R, McCarthy K, Nichols R, Yoksan S, Duan X, Ermak TH, Kanesa-Thasan N, Bedford P, Lang J, Quentin-Millet MJ, Monath TP: Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Hum Vaccin. 2006, 2: 60-67.PubMedCrossRef Guirakhoo F, Kitchener S, Morrison D, Forrat R, McCarthy K, Nichols R, Yoksan S, Duan X, Ermak TH, Kanesa-Thasan N, Bedford P, Lang J, Quentin-Millet MJ, Monath TP: Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Hum Vaccin. 2006, 2: 60-67.PubMedCrossRef
29.
go back to reference Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ, Rice CM: Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A. 1990, 87: 8898-8902. 10.1073/pnas.87.22.8898.PubMedPubMedCentralCrossRef Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ, Rice CM: Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A. 1990, 87: 8898-8902. 10.1073/pnas.87.22.8898.PubMedPubMedCentralCrossRef
30.
go back to reference Nielsen H, Engelbrecht J, Brunak S, von Heijne G: Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997, 10: 1-6. 10.1093/protein/10.1.1.PubMedCrossRef Nielsen H, Engelbrecht J, Brunak S, von Heijne G: Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997, 10: 1-6. 10.1093/protein/10.1.1.PubMedCrossRef
31.
go back to reference Lobigs M, Lee E: Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J Virol. 2004, 78: 178-186. 10.1128/JVI.78.1.178-186.2004.PubMedPubMedCentralCrossRef Lobigs M, Lee E: Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J Virol. 2004, 78: 178-186. 10.1128/JVI.78.1.178-186.2004.PubMedPubMedCentralCrossRef
32.
go back to reference Marchevsky RS, Mariano J, Ferreira VS, Almeida E, Cerqueira MJ, Carvalho R, Pissurno JW, da Rosa AP, Simoes MC, Santos CN, et al: Phenotypic analysis of yellow fever virus derived from complementary DNA. Am J Trop Med Hyg. 1995, 52: 75-80.PubMed Marchevsky RS, Mariano J, Ferreira VS, Almeida E, Cerqueira MJ, Carvalho R, Pissurno JW, da Rosa AP, Simoes MC, Santos CN, et al: Phenotypic analysis of yellow fever virus derived from complementary DNA. Am J Trop Med Hyg. 1995, 52: 75-80.PubMed
33.
go back to reference Chu PW, Westaway EG: Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication. Virology. 1985, 140: 68-79. 10.1016/0042-6822(85)90446-5.PubMedCrossRef Chu PW, Westaway EG: Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication. Virology. 1985, 140: 68-79. 10.1016/0042-6822(85)90446-5.PubMedCrossRef
34.
go back to reference Post PR, Carvalho R, Galler R: Glycosylation and secretion of yellow fever virus nonstructural protein NS1. Virus Res. 1991, 18: 291-302. 10.1016/0168-1702(91)90025-Q.PubMedCrossRef Post PR, Carvalho R, Galler R: Glycosylation and secretion of yellow fever virus nonstructural protein NS1. Virus Res. 1991, 18: 291-302. 10.1016/0168-1702(91)90025-Q.PubMedCrossRef
35.
go back to reference Lorenz IC, Kartenbeck J, Mezzacasa A, Allison SL, Heinz FX, Helenius A: Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol. 2003, 77: 4370-4382. 10.1128/JVI.77.7.4370-4382.2003.PubMedPubMedCentralCrossRef Lorenz IC, Kartenbeck J, Mezzacasa A, Allison SL, Heinz FX, Helenius A: Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol. 2003, 77: 4370-4382. 10.1128/JVI.77.7.4370-4382.2003.PubMedPubMedCentralCrossRef
36.
go back to reference Op De Beeck A, Rouille Y, Caron M, Duvet S, Dubuisson J: The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals. J Virol. 2004, 78: 12591-12602. 10.1128/JVI.78.22.12591-12602.2004.PubMedPubMedCentralCrossRef Op De Beeck A, Rouille Y, Caron M, Duvet S, Dubuisson J: The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals. J Virol. 2004, 78: 12591-12602. 10.1128/JVI.78.22.12591-12602.2004.PubMedPubMedCentralCrossRef
37.
go back to reference Mackenzie JM, Westaway EG: Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol. 2001, 75: 10787-10799. 10.1128/JVI.75.22.10787-10799.2001.PubMedPubMedCentralCrossRef Mackenzie JM, Westaway EG: Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol. 2001, 75: 10787-10799. 10.1128/JVI.75.22.10787-10799.2001.PubMedPubMedCentralCrossRef
38.
go back to reference Yu CY, Hsu YW, Liao CL, Lin YL: Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol. 2006, 80: 11868-11880. 10.1128/JVI.00879-06.PubMedPubMedCentralCrossRef Yu CY, Hsu YW, Liao CL, Lin YL: Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol. 2006, 80: 11868-11880. 10.1128/JVI.00879-06.PubMedPubMedCentralCrossRef
39.
go back to reference Lefeuvre A, Contamin H, Decelle T, Fournier C, Lang J, Deubel V, Marianneau P: Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Microbes Infect. 2006, 8: 1530-1538. 10.1016/j.micinf.2006.01.013.PubMedCrossRef Lefeuvre A, Contamin H, Decelle T, Fournier C, Lang J, Deubel V, Marianneau P: Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Microbes Infect. 2006, 8: 1530-1538. 10.1016/j.micinf.2006.01.013.PubMedCrossRef
40.
go back to reference WHO: WHO Expert Committee on Biological Standardization. Forty-sixth Report. World Health Organ Tech Rep Ser. 1998, 872: i-vii, 1-90. WHO: WHO Expert Committee on Biological Standardization. Forty-sixth Report. World Health Organ Tech Rep Ser. 1998, 872: i-vii, 1-90.
41.
go back to reference Bredenbeek PJ, Molenkamp R, Spaan WJ, Deubel V, Marianneau P, Salvato MS, Moshkoff D, Zapata J, Tikhonov I, Patterson J, Carrion R, Ticer A, Brasky K, Lukashevich IS: A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology. 2006, 345: 299-304. 10.1016/j.virol.2005.12.001.PubMedPubMedCentralCrossRef Bredenbeek PJ, Molenkamp R, Spaan WJ, Deubel V, Marianneau P, Salvato MS, Moshkoff D, Zapata J, Tikhonov I, Patterson J, Carrion R, Ticer A, Brasky K, Lukashevich IS: A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology. 2006, 345: 299-304. 10.1016/j.virol.2005.12.001.PubMedPubMedCentralCrossRef
42.
go back to reference Rice CM, Grakoui A, Galler R, Chambers TJ: Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1989, 1: 285-296.PubMed Rice CM, Grakoui A, Galler R, Chambers TJ: Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1989, 1: 285-296.PubMed
43.
go back to reference Caufour PS, Motta MC, Yamamura AM, Vazquez S, Ferreira, Jabor AV, Bonaldo MC, Freire MS, Galler R: Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses. Virus Res. 2001, 79: 1-14. 10.1016/S0168-1702(01)00273-8.PubMedCrossRef Caufour PS, Motta MC, Yamamura AM, Vazquez S, Ferreira, Jabor AV, Bonaldo MC, Freire MS, Galler R: Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses. Virus Res. 2001, 79: 1-14. 10.1016/S0168-1702(01)00273-8.PubMedCrossRef
44.
go back to reference Galler R, Pugachev KV, Santos CL, Ocran SW, Jabor AV, Rodrigues SG, Marchevsky RS, Freire MS, Almeida LF, Cruz AC, Yamamura AM, Rocco IM, da Rosa ES, Souza LT, Vasconcelos PF, Guirakhoo F, Monath TP: Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology. 2001, 290: 309-319. 10.1006/viro.2001.1168.PubMedCrossRef Galler R, Pugachev KV, Santos CL, Ocran SW, Jabor AV, Rodrigues SG, Marchevsky RS, Freire MS, Almeida LF, Cruz AC, Yamamura AM, Rocco IM, da Rosa ES, Souza LT, Vasconcelos PF, Guirakhoo F, Monath TP: Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology. 2001, 290: 309-319. 10.1006/viro.2001.1168.PubMedCrossRef
45.
go back to reference Marchevsky RS, Freire MS, Coutinho ES, Galler R: Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys. Virology. 2003, 316: 55-63. 10.1016/S0042-6822(03)00583-X.PubMedCrossRef Marchevsky RS, Freire MS, Coutinho ES, Galler R: Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys. Virology. 2003, 316: 55-63. 10.1016/S0042-6822(03)00583-X.PubMedCrossRef
Metadata
Title
Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes
Authors
Myrna C Bonaldo
Samanta M Mello
Gisela F Trindade
Aymara A Rangel
Adriana S Duarte
Prisciliana J Oliveira
Marcos S Freire
Claire F Kubelka
Ricardo Galler
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2007
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-4-115

Other articles of this Issue 1/2007

Virology Journal 1/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.